Trial Outcomes & Findings for Preoperative Jumpstart for Decolonization of P. Acnes (NCT NCT03466658)

NCT ID: NCT03466658

Last Updated: 2020-01-06

Results Overview

The primary outcome measures the intraoperative culture results (e.g. positive vs negative, days to positive conversion) for P. acnes by evaluating bacterial cultures from punch skin biopsies at the time of the surgery.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

17 participants

Primary outcome timeframe

7 days post-biopsy

Results posted on

2020-01-06

Participant Flow

Participants were recruited in the Penn State Health Orthopedics Clinic for indications of open or arthroscopic shoulder surgery.

17 participants met inclusion criteria and were enrolled. 3 participants withdrew prior to study intervention.

Unit of analysis: Shoulder

Participant milestones

Participant milestones
Measure
All Participants
Enrolled participants served as their own control. The surgical shoulder served as the Treatment Shoulder with the Jumpstart dressing intervention, while the normal non-operative contralateral shoulder served as the Control Shoulder.
Overall Study
STARTED
17 34
Overall Study
COMPLETED
14 28
Overall Study
NOT COMPLETED
3 6

Reasons for withdrawal

Reasons for withdrawal
Measure
All Participants
Enrolled participants served as their own control. The surgical shoulder served as the Treatment Shoulder with the Jumpstart dressing intervention, while the normal non-operative contralateral shoulder served as the Control Shoulder.
Overall Study
Withdrawal by Subject
3

Baseline Characteristics

Enrolled participants served as their own control, where both shoulders of each participant will be included for the study. The surgical side shoulder will serve as a Treatment Shoulder with the Jumpstart dressing intervention, while the normal non-operative contralateral shoulder will serve as a Control Shoulder.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Participants
n=17 Participants
Enrolled participants served as their own control. The surgical shoulder served as the Treatment Shoulder with the Jumpstart dressing intervention, while the normal non-operative contralateral shoulder served as the Control Shoulder.
Age, Continuous
61 years
n=99 Participants
Sex: Female, Male
Female
8 Participants
n=99 Participants
Sex: Female, Male
Male
9 Participants
n=99 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=99 Participants
Race (NIH/OMB)
White
16 Participants
n=99 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
Region of Enrollment
United States
17 participants
n=99 Participants • Enrolled participants served as their own control, where both shoulders of each participant will be included for the study. The surgical side shoulder will serve as a Treatment Shoulder with the Jumpstart dressing intervention, while the normal non-operative contralateral shoulder will serve as a Control Shoulder.

PRIMARY outcome

Timeframe: 7 days post-biopsy

Population: Data not analyzed due to unexpected culture contamination.

The primary outcome measures the intraoperative culture results (e.g. positive vs negative, days to positive conversion) for P. acnes by evaluating bacterial cultures from punch skin biopsies at the time of the surgery.

Outcome measures

Outcome data not reported

Adverse Events

JumpStart Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Hyunmin Kim

Penn State Health

Phone: 717-531-4826

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place